Skip to Content

Sunmark Gas relief

Medically reviewed on April 10, 2018

Dosage form: tablet, chewable
Ingredients: DIMETHICONE 80mg
Labeler: McKesson
NDC Code: 49348-509

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Sunmark Gas Relief

Active ingredient (in each tablet)

Simethicone 80 mg

Purpose

Anti-gas

Uses

relieves

  • pressure
  • bloating
  • symptoms referred to as gas

Warnings

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center immediately.

Directions
  • chew 1 to 2 tablets thoroughly as needed after meals and at bedtime
  • do not exceed 6 tablets per day unless directed by a physician.

Other information

  • do not use if any individual blister unit is broken or open.
  • store at room temperature.
  • avoid high humidity and excessive heat, above 40°C (104°F)

Inactive ingredients

compressible sugar, dextrose, flavors, magnesium stearate, maltodextrin, microcrystalline cellulose, sorbitol

Principal Display Panel

Sunmark

COMPARE TO GAS-X® ACTIVE INGREDIENT

gas relief

Regular Strength

Fast relief of pressure, bloating & discomfort of gas

SIMETHICONE 80 mg

Peppermint creme

36 Chewable Tablets

SUNMARK GAS RELIEF 
dimethicone tablet, chewable
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49348-509
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DIMETHICONE (DIMETHICONE) DIMETHICONE80 mg
Inactive Ingredients
Ingredient NameStrength
RAW SUGAR 
DEXTROSE 
MAGNESIUM STEARATE 
MALTODEXTRIN 
CELLULOSE, MICROCRYSTALLINE 
SORBITOL 
Product Characteristics
ColorwhiteScoreno score
ShapeROUNDSize14mm
FlavorPEPPERMINTImprint CodeGDC156
Contains    
Packaging
#Item CodePackage Description
1NDC:49348-509-073 BLISTER PACK in 1 CARTON
112 TABLET, CHEWABLE in 1 BLISTER PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart33204/10/2004
Labeler - McKesson (177667227)

 
McKesson

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide